Athira Pharma, Inc. — Director's Dealing 2021

Mar 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2021-03-04

Reporting Person: Kosacz Barbara (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-04	Stock Option (Right to Buy)	$19.29	A	27742	Acquired	2031-03-03	Common Stock (27742)	Direct

Footnotes

F1: One thirty-sixth of the shares subject to the option will vest on April 4, 2021 and one thirty-sixth of the shares subject to the option will vest each month thereafter.